Primarily utilized in the field of oncology research, it serves as a potent inhibitor targeting specific enzymes involved in cancer cell metabolism. Its role is crucial in studying the inhibition of lactate dehydrogenase A (LDHA), an enzyme that cancer cells rely on for energy production under low oxygen conditions. By blocking LDHA, it disrupts the energy supply to cancer cells, potentially leading to their death. This makes it a valuable tool in preclinical studies aimed at understanding and developing new therapeutic strategies for treating various types of cancer, particularly those characterized by high metabolic activity and hypoxia. Researchers also explore its potential in combination therapies to enhance the efficacy of existing cancer treatments.